BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31525280)

  • 21. High bone mass from mutation of low-density lipoprotein receptor-related protein 6 (LRP6).
    Brance ML; Brun LR; Cóccaro NM; Aravena A; Duan S; Mumm S; Whyte MP
    Bone; 2020 Dec; 141():115550. PubMed ID: 32730923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history.
    Cohen A; Lang TF; McMahon DJ; Liu XS; Guo XE; Zhang C; Stein EM; Dempster DW; Young P; Saeed I; Lappe JM; Recker RR; Shane E
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4244-52. PubMed ID: 22962425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High bone density due to a mutation in LDL-receptor-related protein 5.
    Boyden LM; Mao J; Belsky J; Mitzner L; Farhi A; Mitnick MA; Wu D; Insogna K; Lifton RP
    N Engl J Med; 2002 May; 346(20):1513-21. PubMed ID: 12015390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High bone mass in mice expressing a mutant LRP5 gene.
    Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F
    J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Analysis in a Familial Case With High Bone Mineral Density Suggests Additive Effects at Two Loci.
    Martínez-Gil N; Ovejero D; Garcia-Giralt N; Bruque CD; Mellibovsky L; Nogués X; Rabionet R; Grinberg D; Balcells S
    JBMR Plus; 2022 Apr; 6(4):e10602. PubMed ID: 35434450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical and Trabecular Bone Analysis of Patients With High Bone Mass From the Barcelona Osteoporosis Cohort Using 3-Dimensional Dual-Energy X-ray Absorptiometry: A Case-Control Study.
    Orduna G; Humbert L; Fonolla R; Romera J; Cos ML; Rial A; Nogués X; Diez-Perez A; Mellibovsky L
    J Clin Densitom; 2018; 21(4):480-484. PubMed ID: 28648836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a rare
    Walcott BP; Winkler EA; Zhou S; Birk H; Guo D; Koch MJ; Stapleton CJ; Spiegelman D; Dionne-Laporte A; Dion PA; Kahle KT; Rouleau GA; Lawton MT
    Hum Genome Var; 2018; 5():18001. PubMed ID: 29844917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Level and change in bone microarchitectural parameters and their relationship with previous fracture and established bone mineral density loci.
    Fuggle NR; Westbury LD; Bevilacqua G; Titcombe P; Ó Breasail M; Harvey NC; Dennison EM; Cooper C; Ward KA
    Bone; 2021 Jun; 147():115937. PubMed ID: 33766802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice.
    Andersson N; Lindberg MK; Ohlsson C; Andersson K; Ryberg B
    J Endocrinol; 2001 Sep; 170(3):529-37. PubMed ID: 11524233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65).
    Frederiksen AL; Larsen MJ; Brusgaard K; Novack DV; Knudsen PJ; Schrøder HD; Qiu W; Eckhardt C; McAlister WH; Kassem M; Mumm S; Frost M; Whyte MP
    J Bone Miner Res; 2016 Jan; 31(1):163-72. PubMed ID: 26178921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
    Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
    J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II).
    Butscheidt S; Rolvien T; Kornak U; Schmidt FN; Schinke T; Amling M; Oheim R
    Calcif Tissue Int; 2018 Jan; 102(1):41-52. PubMed ID: 29018903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Lv F; Ma M; Liu W; Xu X; Song Y; Li L; Jiang Y; Wang O; Xia W; Xing X; Qiu Z; Li M
    Osteoporos Int; 2017 Sep; 28(9):2691-2700. PubMed ID: 28620780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: a peripheral quantitative computed tomography (pQCT) study.
    Gaudio A; Pennisi P; Muratore F; Bertino G; Ardiri A; Pulvirenti I; Tringali G; Fiore CE
    Eur J Intern Med; 2012 Oct; 23(7):656-60. PubMed ID: 22892442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral Adipose Tissue Is Associated With Bone Microarchitecture in the Framingham Osteoporosis Study.
    Liu CT; Broe KE; Zhou Y; Boyd SK; Cupples LA; Hannan MT; Lim E; McLean RR; Samelson EJ; Bouxsein ML; Kiel DP
    J Bone Miner Res; 2017 Jan; 32(1):143-150. PubMed ID: 27487454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure.
    Paternoster L; Lorentzon M; Lehtimäki T; Eriksson J; Kähönen M; Raitakari O; Laaksonen M; Sievänen H; Viikari J; Lyytikäinen LP; Mellström D; Karlsson M; Ljunggren O; Grundberg E; Kemp JP; Sayers A; Nethander M; Evans DM; Vandenput L; Tobias JH; Ohlsson C
    PLoS Genet; 2013; 9(2):e1003247. PubMed ID: 23437003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
    Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.